Adstiladrin
Term · Oncology and biomedicine · MLC-T-ONC-000278
A drug used to treat adults with a certain type of high-risk bladder cancer that has not invaded the muscle layers of the bladder. It is used in patients whose cancer has not gotten better after treatment with Bacillus Calmette-Guérin (BCG). It is also being studied in the treatment of other types of cancer. Adstiladrin is a weakened adenovirus that carries a copy of the gene for interferon alfa-2b into bladder cancer cells. This may help the body’s immune system recognize the cancer cells and kill them. Adstiladrin is given in a solution that is placed directly into the bladder using a thin tube called a catheter. It is a type of gene therapy. Also called nadofaragene firadenovec.
| Identifier | MLC-T-ONC-000278 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | nadofaragene firadenovec |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000278",
"term": "Adstiladrin",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat adults with a certain type of high-risk bladder cancer that has not invaded the muscle layers of the bladder. It is used in patients whose cancer has not gotten better after treatment with Bacillus Calmette-Guérin (BCG). It is also being studied in the treatment of other types of cancer. Adstiladrin is a weakened adenovirus that carries a copy of the gene for interferon alfa-2b into bladder cancer cells. This may help the body’s immune system recognize the cancer cells and kill them. Adstiladrin is given in a solution that is placed directly into the bladder using a thin tube called a catheter. It is a type of gene therapy. Also called nadofaragene firadenovec.",
"synonyms": [
"nadofaragene firadenovec"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/adstiladrin/"
}
Record 484 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.